Titre :
|
Analysis of Herpes simplex virus 1 and 2 infection in women with high risk sexual behaviour in Mexico. (1999)
|
Auteurs :
|
C.J. CONDE-GLEZ ;
E. CALDERON ;
M. HERNANDEZ-AVILA ;
P. HERNANDEZ-NEVAREZ ;
L. JUAREZ-FIGUEROA ;
D.S. SCHMID ;
F. URIBE-SALAS ;
National Institute of Public Health. CP Cuernavaca Morelos. MEX
|
Type de document :
|
Article
|
Dans :
|
International journal of epidemiology (vol. 28, n° 3, 1999)
|
Pagination :
|
571-576
|
Langues:
|
Anglais
|
Mots-clés :
|
Herpès
;
Virose
;
Infection
;
Prostitution
;
Comportement sexuel
;
Risque
;
Epidémiologie
;
Facteur risque
;
Prévalence
;
Homme
;
Femme
;
Mexique
;
Amérique
;
Amérique centrale
|
Résumé :
|
[BDSP. Notice produite par INIST rb9R0xcA. Diffusion soumise à autorisation]. Background This paper describes the seroprevalence and risk factors of Herpes simplex virus (HSV) infection in a group of female prostitutes from Mexico City. Methods Women who consented to participate in the study voluntarily attended a sexually transmitted disease (STD) clinic during 1992. A standardized questionnaire was administered and a blood sample was obtained from each participant. Type-specific Western blot serology was performed to determine the serostatus of HSV-1 and HSV-2 for participants. Bivariate and multivariate analyses were applied to identify variables associated with an increased risk for HSV infection. Results Prevalences of infection among the 997 prostitutes studied were 93.9% for HSV-1 and 60.8% for HSV-2. Only 1.8% of the women were seronegative for both viruses. The only variable associated with HSV-1 seropositivity was crowding index. The following variables were associated with an increased risk for infection with HSV-2 : age, level of education, working site, born outside Mexico City and increasing time as a prostitute. Conclusions This is the first assessment of HSV infection in Mexico and may be useful for the development and application of control and preventive measures among the prostitute population at risk of acquiring and transmitting human immunodeficiency virus (HIV) and other STD.
|